Joseph Chang
No más puestos en curso
Fortuna: 1 M $ al 31/05/2024
Perfil
Joseph Y.
Chang served as the Lead Independent Director at Optimer Pharmaceuticals LLC from 2012 to 2013.
Prior to that, he was the Vice President-Clinical Studies & Pharmacology at Pharmanex, Inc. from 1998 to 2006.
He also held the position of President & Chief Scientific Officer at Binary Therapeutics, Inc. from 1994 to 1997 and at Osteoarthritis Sciences, Inc. from 1991 to 1994.
Currently, he is the Chief Scientific Officer & EVP-Product Development at Nu Skin Enterprises, Inc. since 1997.
Dr. Chang obtained a doctorate degree from the University of London in 1978 and an undergraduate degree from the University of Portsmouth.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 08/04/2024 | 92 441 ( 0.19% ) | 1 M $ | 31/05/2024 |
Antiguos cargos conocidos de Joseph Chang.
| Empresas | Cargo | Fin |
|---|---|---|
| NU SKIN ENTERPRISES, INC. | Director Técnico/Científico/I+D | 30/03/2024 |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Director/Miembro de la Junta | 24/10/2013 |
Pharmanex, Inc.
 Pharmanex, Inc. Food RetailRetail Trade Pharmanex, Inc. provided dietary supplement products. It offered anti aging with nutritional supplement products. The company was founded by William E. McGlashan Jr. and Michael N. Chang in 1994 and was headquartered in Provo, UT. | Corporate Officer/Principal | 01/02/2006 |
| Binary Therapeutics, Inc. | Presidente | 01/01/1997 |
| Osteoarthritis Sciences, Inc. | Presidente | 01/01/1994 |
Formación de Joseph Chang.
| University of Portsmouth | Undergraduate Degree |
| University of London | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NU SKIN ENTERPRISES, INC. | Consumer Non-Durables |
| Empresas privadas | 4 |
|---|---|
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Health Technology |
| Binary Therapeutics, Inc. | |
Pharmanex, Inc.
Pharmanex, Inc. Food RetailRetail Trade Pharmanex, Inc. provided dietary supplement products. It offered anti aging with nutritional supplement products. The company was founded by William E. McGlashan Jr. and Michael N. Chang in 1994 and was headquartered in Provo, UT. | Retail Trade |
| Osteoarthritis Sciences, Inc. |
- Bolsa de valores
- Insiders
- Joseph Chang
